99 related articles for article (PubMed ID: 25169525)
1. Receiver operating characteristic curve analysis of SEER medulloblastoma and primitive neuroectodermal tumor (PNET) outcome data: identification and optimization of predictive models.
Cheung MR
Asian Pac J Cancer Prev; 2014; 15(16):6781-5. PubMed ID: 25169525
[TBL] [Abstract][Full Text] [Related]
2. Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis.
Cheung R
Asian Pac J Cancer Prev; 2012; 13(9):4587-91. PubMed ID: 23167385
[TBL] [Abstract][Full Text] [Related]
3. Optimization of predictors of Ewing sarcoma cause-specific survival: a population study.
Cheung MR
Asian Pac J Cancer Prev; 2014; 15(10):4143-5. PubMed ID: 24935360
[TBL] [Abstract][Full Text] [Related]
4. Analysis of SEER Glassy Cell Carcinoma Data: Underuse of Radiotherapy and Predicators of Cause Specific Survival.
Cheung R
Asian Pac J Cancer Prev; 2016; 17(1):353-6. PubMed ID: 26838236
[TBL] [Abstract][Full Text] [Related]
5. Analysis of SEER Adenosquamous Carcinoma Data to Identify Cause Specific Survival Predictors and Socioeconomic Disparities.
Cheung R
Asian Pac J Cancer Prev; 2016; 17(1):347-52. PubMed ID: 26838235
[TBL] [Abstract][Full Text] [Related]
6. Surveying and optimizing the predictors for ependymoma specific survival using SEER data.
Cheung MR
Asian Pac J Cancer Prev; 2014; 15(2):867-70. PubMed ID: 24568509
[TBL] [Abstract][Full Text] [Related]
7. Under-use of radiotherapy in stage III bronchioaveolar lung cancer and socio-economic disparities in cause specific survival: a population study.
Cheung MR
Asian Pac J Cancer Prev; 2014; 15(9):4091-4. PubMed ID: 24935602
[TBL] [Abstract][Full Text] [Related]
8. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
9. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
10. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results.
McNeil DE; Coté TR; Clegg L; Rorke LB
Med Pediatr Oncol; 2002 Sep; 39(3):190-4. PubMed ID: 12210449
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
12. Racial and socioeconomic disparities in malignant carcinoid cancer cause specific survival: analysis of the surveillance, epidemiology and end results national cancer registry.
Cheung R
Asian Pac J Cancer Prev; 2013; 14(12):7117-20. PubMed ID: 24460261
[TBL] [Abstract][Full Text] [Related]
13. [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].
Sato H; Shibuya K; Koizumi T; Kato S; Endo S
No Shinkei Geka; 2014 Jul; 42(7):641-50. PubMed ID: 25006105
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
[TBL] [Abstract][Full Text] [Related]
15. Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs).
Smoll NR
Cancer; 2012 Mar; 118(5):1313-22. PubMed ID: 21837678
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
17. Assessing the impact of socio-economic variables on breast cancer treatment outcome disparity.
Cheung MR
Asian Pac J Cancer Prev; 2013; 14(12):7133-6. PubMed ID: 24460264
[TBL] [Abstract][Full Text] [Related]
18. Using SEER data to quantify effects of low income neighborhoods on cause specific survival of skin melanoma.
Cheung MR
Asian Pac J Cancer Prev; 2013; 14(5):3219-21. PubMed ID: 23803107
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
